Skip to main content
. 2021 Jul 2;7:55. doi: 10.1038/s41531-021-00198-3

Table 1.

Summary of the healthy controls and patients used in this study.

Cell line code Status Code used in this study Sex Age at donation Age at onset LRRK2 mutation Isogenic control
SP-11 Control CTR F 48 No
SP-11TH Control CTR TH F 48 No
SP-12wt/wt Isogenic Control isoPD1 F 63 G2019S LRRK2G2019S corrected
SP-12 L2-PD PD1 F 63 49 G2019S
SP-12TH L2-PD PD1 TH F 63 49 G2019S
SP-12THwt/wt Isogenic Control Iso PD1TH F 63 G2019S LRRK2G2019S corrected
SP-13 L2-PD PD2 F 68 57 G2019S